Plain-English translation of NCT05778006 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This is a research registry—a database where people with ME/CFS share information about their condition to help doctors and scientists learn more about the disease. Researchers are particularly interested in ME/CFS that develops after infections like COVID-19, mononucleosis, or the flu. By joining, you'll help identify patterns in how the disease progresses and what treatments might work best.
ME/CFS is a serious, disabling condition that affects hundreds of thousands of people, yet doctors still don't fully understand what causes it or how to treat it effectively. This registry aims to change that by collecting detailed health information from many patients, so researchers can discover subtypes of the disease, identify risk factors, and design better clinical trials in the future.
You likely qualify if…
You likely don't qualify if…
You will complete a web-based questionnaire and share details about your medical history, symptoms, and how ME/CFS has affected your life. You may also be invited to donate blood or other samples for future research. The registry is based in Germany and conducted online, so you can participate from home at times that work for you.
AI-generated summary from trial data · Jun 3, 2026 · Not medical advice
Germany
Collaborators
Charite University, Berlin, Germany
Enrollment target
~650 participants
Started
May 2022
Primary completion
May 2052
Age range
0 Years and older
Last updated on clinicaltrials.gov in January 2025.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Uta Behrends, Prof. Dr. med.
MRI Chronic Fatigue Center for Young People (MCFC) Children's Hospital, Technical University of Munich & Munich Municipal Hospital
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.